EmtinB （NeuroScientific Biopharmaceuticals Ltd）

N/A

Report date: 2023/04/04 16:57:21

Base Information

Drug NameEmtinB （NeuroScientific Biopharmaceuticals Ltd）
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionLDL receptor agonists
TargetsLDL receptor
Therapy Area/IndicationsGlaucomaOptic AtrophyAlzheimer Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsGlaucomaOptic AtrophyAlzheimer Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A